000 01864 a2200505 4500
005 20250515121827.0
264 0 _c20081125
008 200811s 0 0 eng d
022 _a0007-1188
024 7 _a10.1038/bjp.2008.186
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFagerholm, V
245 0 0 _aalpha2A-adrenoceptor antagonism increases insulin secretion and synergistically augments the insulinotropic effect of glibenclamide in mice.
_h[electronic resource]
260 _bBritish journal of pharmacology
_cJul 2008
300 _a1287-96 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdrenergic alpha-2 Receptor Antagonists
650 0 4 _aAdrenergic alpha-Antagonists
_xpharmacology
650 0 4 _aAdrenergic beta-Antagonists
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aAtropine Derivatives
_xpharmacology
650 0 4 _aBenzofurans
_xpharmacology
650 0 4 _aBlood Glucose
_xmetabolism
650 0 4 _aDrug Synergism
650 0 4 _aFasting
_xphysiology
650 0 4 _aGlyburide
_xpharmacology
650 0 4 _aHypoglycemic Agents
_xpharmacology
650 0 4 _aImidazoles
_xpharmacology
650 0 4 _aInsulin
_xblood
650 0 4 _aInsulin Secretion
650 0 4 _aIsoquinolines
_xpharmacology
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aMice, Knockout
650 0 4 _aMuscarinic Antagonists
_xpharmacology
650 0 4 _aNaphthyridines
_xpharmacology
650 0 4 _aPhentolamine
_xpharmacology
650 0 4 _aPropranolol
_xpharmacology
650 0 4 _aReceptors, Adrenergic, alpha-2
_xgenetics
700 1 _aScheinin, M
700 1 _aHaaparanta, M
773 0 _tBritish journal of pharmacology
_gvol. 154
_gno. 6
_gp. 1287-96
856 4 0 _uhttps://doi.org/10.1038/bjp.2008.186
_zAvailable from publisher's website
999 _c17987309
_d17987309